Bicarbonate

Bicarbonate

SCHEMBL2277863

CCCCCCCC[N+](C)(C)C.CCCCCCCC[N+](C)(C)C.O=C([O-])[O-]

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 7/20 0.71
APAF1 O14727 1/20 0.65
HSP90AA1 P07900 1/20 0.65
RAD52 P43351 1/20 0.65
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
APEX1 P27695 3/20 0.52
NFKB1 P19838 2/20 0.52
KDM4E B2RXH2 2/20 0.52
ACHE P22303 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
PMP22 Q01453 2/20 0.52
LMNA P02545 2/20 0.52
HSD17B10 Q99714 1/20 0.52
HRH3 Q9Y5N1 1/20 0.52
TSHR P16473 1/20 0.52
RAB9A P51151 1/20 0.52
LSS P48449 1/20 0.52
NPSR1 Q6W5P4 1/20 0.50
HTT P42858 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL17199723 1.00 DNM1 (0.71) DNM1APAF1HSP90AA1RAD52MEN1
Bicarbonate SCHEMBL30658529 1.00 DNM1 (0.71) DNM1APAF1HSP90AA1RAD52MEN1
Bicarbonate SCHEMBL28963226 1.00 DNM1 (0.71) DNM1APAF1HSP90AA1RAD52MEN1
Bicarbonate SCHEMBL9724753 1.00 DNM1 (0.71) DNM1APAF1HSP90AA1RAD52MEN1
Bicarbonate SCHEMBL2273896 1.00 DNM1 (0.71) DNM1APAF1HSP90AA1RAD52MEN1
Cetrimonium SCHEMBL9694475 1.00 DNM1 (0.71) DNM1APAF1HSP90AA1RAD52MEN1
Bicarbonate SCHEMBL2277610 1.00 DNM1 (0.71) DNM1APAF1HSP90AA1RAD52MEN1
Bicarbonate SCHEMBL2278386 1.00 DNM1 (0.71) DNM1APAF1HSP90AA1RAD52MEN1
Bicarbonate SCHEMBL2278708 1.00 DNM1 (0.71) DNM1APAF1HSP90AA1RAD52MEN1
Bicarbonate SCHEMBL2276707 1.00 DNM1 (0.71) DNM1APAF1HSP90AA1RAD52MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4717720-A1 CATALYST COMPOSITION, BLOCKED POLYISOCYANATE COMPOSITION, COATING MATERIAL COMPOSITION, COATING FILM, AND METHOD FOR FORMING COATING FILM Tosoh Corporation (JP) 2026-04-01 EP disclosed
EP-4678676-A1 BLOCKED POLYISOCYANATE COMPOSITION, CURING AGENT FOR AQUEOUS COATING, AQUEOUS COATING COMPOSITION, AND COATING FILM Tosoh Corporation (JP) 2026-01-14 EP disclosed
WO-2024262553-A1 CATALYST COMPOSITION, BLOCKED POLYISOCYANATE COMPOSITION, COATING MATERIAL COMPOSITION, COATING FILM, AND METHOD FOR FORMING COATING FILM 東ソー株式会社 2024-12-26 WO disclosed
WO-2024202500-A1 BLOCKED POLYISOCYANATE COMPOSITION, CURING AGENT FOR AQUEOUS COATING, AQUEOUS COATING COMPOSITION, AND COATING FILM 東ソー株式会社 2024-10-03 WO disclosed
CN-117440929-B Method for producing layered silicate and use thereof in production of silica nanosheets 日产化学株式会社 2024-08-23 CN disclosed
CN-117157249-B Cage silicate and method for producing same 日产化学株式会社 2024-08-13 CN disclosed
US-12012368-B2 Cage silicate and method for producing the same NISSAN CHEMICAL CORPORATION (JP) 2024-06-18 US disclosed
US-11999625-B2 Method of producing layered silicate, and application thereof in production of silica nanosheet and so on NISSAN CHEMICAL CORPORATION (JP) 2024-06-04 US disclosed
US-20240051834-A1 METHOD OF PRODUCING LAYERED SILICATE, AND APPLICATION THEREOF IN PRODUCTION OF SILICA NANOSHEET AND SO ON NISSAN CHEMICAL CORPORATION (JP) 2024-02-15 US disclosed
US-20240051913-A1 CAGE SILICATE AND METHOD FOR PRODUCING THE SAME NISSAN CHEMICAL CORPORATION (JP) 2024-02-15 US disclosed
US-20120220025-A1 PROCESS FOR ACCELERATED CAPTURE OF CARBON DIOXIDE AKERMIN, INC. (US) 2012-08-30 US disclosed
US-8178332-B2 Process for accelerated capture of carbon dioxide AKERMIN, INC. (US) 2012-05-15 US disclosed
EP-2362809-A2 PROCESS FOR ACCELERATED CAPTURE OF CARBON DIOXIDE Akermin, Inc. (US) 2011-09-07 EP disclosed
US-7998714-B2 Process for accelerated capture of carbon dioxide AKERMIN, INC. (US) 2011-08-16 US disclosed
US-20100086983-A1 PROCESS FOR ACCELERATED CAPTURE OF CARBON DIOXIDE AKERMIN, INC. (US) 2010-04-08 US disclosed
WO-2010037109-A2 PROCESS FOR ACCELERATED CAPTURE OF CARBON DIOXIDE AKERMIN, INC. (US) 2010-04-01 WO disclosed
EP-0839841-B1 Anti-bacterial water absorbing agent and anti-bacterial water absorbent material SANYO CHEMICAL IND LTD (JP) 2009-05-06 EP disclosed
US-6680286-B1 CONTAINING AN ORGANIC POLYELECTROLYTE BUILDER, QUATERNARY AMMONIUM ACRYLIC POLYMERS, WHICH ARE ESPECIALLY USEFUL FOR WASHING CLOTHES SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2004-01-20 US disclosed
US-5981668-A COMPRISING A WATER ABSORBING RESIN HAVING PENDANT ACID GROUPS, AT LEAST ONE ACID GROUP BEING IN THE FORM OF A QUATERNARY AMMONIUM SALT SANYO CHEMICAL INDUSTRIES, LTD. (JP) 1999-11-09 US disclosed
EP-0839841-A2 Anti-bacterial water absorbing agent and anti-bacterial water absorbent material SANYO CHEMICAL INDUSTRIES, LTD. (JP) 1998-05-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12012368-B2 Cage silicate and method for producing the same SIGMAR1, SAE1, SEM1 DNM1 2035/4885APAF1 2111/4885HSP90AA1 2128/4885
US-20240051913-A1 CAGE SILICATE AND METHOD FOR PRODUCING THE SAME ORAI2, SIGMAR1, SEM1 DNM1 2074/4885APAF1 2248/4885HSP90AA1 2305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.